SAM

Sectoral Asset Management Portfolio holdings

AUM $151M
1-Year Est. Return 14.02%
This Quarter Est. Return
1 Year Est. Return
+14.02%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$128M
AUM Growth
-$21.3M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
99
New
Increased
Reduced
Closed

Top Buys

1
+$1.21M
2
+$1.09M
3
+$1.02M
4
RDNT icon
RadNet
RDNT
+$994K
5
SWTX
SpringWorks Therapeutics
SWTX
+$875K

Top Sells

1
+$2.59M
2
+$2.16M
3
+$1.49M
4
SRPT icon
Sarepta Therapeutics
SRPT
+$1.34M
5
HCAT icon
Health Catalyst
HCAT
+$1.13M

Sector Composition

1 Healthcare 99.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRNA icon
76
Moderna
MRNA
$10.6B
$159K 0.12%
5,600
+1,250
AXSM icon
77
Axsome Therapeutics
AXSM
$6.57B
$119K 0.09%
1,020
+200
ORIC icon
78
Oric Pharmaceuticals
ORIC
$1.2B
$112K 0.09%
+20,000
TEM
79
Tempus AI
TEM
$16.1B
$104K 0.08%
+2,160
IOBT icon
80
IO Biotech
IOBT
$54M
$104K 0.08%
95,000
+20,000
ARVN icon
81
Arvinas
ARVN
$714M
$90.8K 0.07%
12,930
-17,220
CRSP icon
82
CRISPR Therapeutics
CRSP
$6.73B
$86.4K 0.07%
+2,540
RXRX icon
83
Recursion Pharmaceuticals
RXRX
$2.92B
$60.8K 0.05%
+11,500
ENGN icon
84
enGene Holdings
ENGN
$478M
$52.4K 0.04%
11,700
-67,219
CI icon
85
Cigna
CI
$81.9B
– –
-2,250
CRGX
86
DELISTED
CARGO Therapeutics
CRGX
– –
-8,500
CVS icon
87
CVS Health
CVS
$105B
– –
-22,000
EW icon
88
Edwards Lifesciences
EW
$44.2B
– –
-7,850
EXEL icon
89
Exelixis
EXEL
$9.3B
– –
-3,500
GERN icon
90
Geron
GERN
$810M
– –
-63,500
HCAT icon
91
Health Catalyst
HCAT
$220M
– –
-160,000
HUM icon
92
Humana
HUM
$34.2B
– –
-1,581
OLMA icon
93
Olema Pharmaceuticals
OLMA
$533M
– –
-61,650
PRVA icon
94
Privia Health
PRVA
$3.24B
– –
-52,000
SRPT icon
95
Sarepta Therapeutics
SRPT
$2.41B
– –
-11,020
TSBX
96
DELISTED
Turnstone Biologics
TSBX
– –
-517,648
ITCI
97
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-4,900
NARI
98
DELISTED
Inari Medical, Inc. Common Stock
NARI
– –
-15,153
IOVA icon
99
Iovance Biotherapeutics
IOVA
$840M
– –
-81,500
1 2 3
4